GALNT2 and rectum adenocarcinoma: In addition, pan-cancer analysis showed that the increased expression of GALNT2 also predicted unfavorable prognosis in several other cancers, including HNSC, KIRC, LUAD, LUSC, STAD, rectum adenocarcinoma (READ) and uterine corpus endometrial carcinoma (UCEC) (Figure 2E).